| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |